about
Radio(chemo)therapy in locally advanced nonsmall cell lung cancerPrimary tumor volume delineation in head and neck cancer: missing the tip of the iceberg?Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.govOutcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.Current Role of Dacomitinib in Head and Neck Cancer.Pectoralis major myofascial interposition flap prevents postoperative pharyngocutaneous fistula in salvage total laryngectomy.Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis.Increase in the rate of HPV positive oropharyngeal cancers during 1996-2011 in a case study in Turkey.Is FDG -PET-CT a valuable tool in prediction of persistent disease in head and neck cancer.T1-2 glottic cancer treated with radiotherapy and/or surgery.Letter to the Editor on Nevens et al.Salvage-Chirurgie bei Tumorrezidiven der Mundhöhle – Einfluss der vorherigen Behandlung und des Patientenalters.Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.The latest prospects of investigational drugs for head and neck cancer.[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial.Part 2: Dynamic mixed beam radiotherapy (DYMBER): Photon dynamic trajectories combined with modulated electron beamsRisk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservationRelation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiationLong-term functional outcome after laryngeal cancer treatment.Part 1: Optimization and evaluation of dynamic trajectory radiotherapyInfluencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter StudyComparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohortComprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent DiseaseA Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell CarcinomaPatients' preferences concerning follow-up after curative head and neck cancer treatment: A cross-sectional pilot studyIs it safe to irradiate the newest generation of ventricular assist devices? A case report and systematic literature reviewComparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their OutcomeEmerging patient-specific treatment modalities in head and neck cancer - a systematic reviewSkin surface markers for stereotactic body radiation therapy of sternal metastasisIncidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients
P50
Q26765355-58A457E2-4291-4BFA-BD7E-C779900FE806Q33816287-C2D2CBBD-AC36-4C60-BED3-48C42294ED2BQ37555973-157D10D1-51DA-4664-B2CF-ECB06BFE1909Q38602875-182A6314-2FD6-40CE-9487-9732BD989F77Q38782390-07284F56-19A1-42CD-BA83-CC134818B551Q38806115-98949AD9-22D8-478F-9C68-03D711C270EEQ38815682-60DA0EC6-4E4D-4D86-82C0-0BC352F37ACCQ38896865-FD1471DC-08C2-44EA-98F9-730539F2A8A5Q40809342-665A59FC-7785-4EBF-8377-312D1883DEADQ42252141-FF395313-56FA-49F8-A432-D8A93EA2EC76Q44728615-85088422-3C98-482D-835F-7056A55BCC2FQ48188439-6520EDA9-685C-4929-BBE9-AFAC56ED6BB4Q50114620-218E6AE0-769C-4874-80B3-48698A8B18FBQ50191734-F1F36F6E-EDDD-41EB-9777-F295179D0621Q50848267-A78249C0-F5B6-43B5-A964-BB9677B2C04CQ52932010-94DC7B03-E406-4CFF-A8AA-0A547F335799Q53038632-607E04F5-77D0-47B4-A9E5-E8E9BD08C006Q54866361-D49DE47C-1171-42C8-B0EA-8EFAD907E73DQ55461051-C41C24E4-09E2-49C6-82CD-7AA959F1B771Q57176636-35271256-E90D-40B9-9A82-7B86D6015094Q57280611-5B831C37-52A6-4D39-90E7-D6618841A151Q58608660-ABBD2C05-F35A-4DD1-8D37-0F7E5D0D0333Q64971453-9E6F8A30-2BC7-44EF-8B76-D8C699649424Q89543799-69DEE686-457B-4347-8121-DFEA5C37F8A6Q90734684-2DA6FD62-D46A-4B96-9E38-206A319E7002Q90798146-74FA2FF1-5348-4492-9E3D-7A741AE6195EQ90946644-D0303EC2-E213-49EB-A28D-257C62A5619EQ91219436-C38590CC-E57B-447C-BB33-A26F11954B4AQ91219440-99A06020-01A9-4F8C-8066-94F8A2251E08Q91219443-F73E8C47-4CAC-4706-BD34-74340F629898Q91219447-F0FD033C-F4E3-4ED6-8A32-8947DC9A4426Q91343896-EFC7BCE2-A6CC-4BEA-AE58-DB638757951FQ91364434-BF21EC5C-BC7F-483B-AB67-E89FFC596913Q91457565-688099DE-074D-450F-9190-5044ABE46E34Q91546273-0D89761B-B887-4327-BD16-98437783E527Q91553057-DD21D308-9924-4424-BD1F-20FB8ED87FF2Q92714755-80EAD516-00DB-4CF5-992C-DF99C40C62E6Q93346283-3312EDDF-1C56-4E03-B922-62C4E3B4D25B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olgun Elicin
@ast
Olgun Elicin
@en
Olgun Elicin
@es
Olgun Elicin
@nl
type
label
Olgun Elicin
@ast
Olgun Elicin
@en
Olgun Elicin
@es
Olgun Elicin
@nl
prefLabel
Olgun Elicin
@ast
Olgun Elicin
@en
Olgun Elicin
@es
Olgun Elicin
@nl
P106
P21
P31
P496
0000-0002-6996-0646